705MO Sitravatinib (sitra) in combination with nivolumab (nivo) demonstrates clinical activity in checkpoint inhibitor (CPI) naïve, platinum-experienced patients (pts) with advanced or metastatic urothelial carcinoma (UC)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Msaouel, P; Siefker-Radtke, AO; Sweis, R; Mao, S; Rosenberg, JE; Vaishampayan, UN; Kalebasty, AR; Pili, R; Bupathi, M; Nordquist, LT; Shaffer, DR; Davis, N; Zhang, T; Gandhi, S; Christensen, J; Shazer, R; Yan, X; Winter, M; Der-Torossian, H; Iyer, GV

Published Date

  • September 2020

Published In

Volume / Issue

  • 31 /

Start / End Page

  • S556 - S556

Published By

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1016/j.annonc.2020.08.777